NCT07153653 Managing Pregnancy Pain With Baduanjin Exercise
| NCT ID | NCT07153653 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | Pregnancy-related Low Back and Pelvic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-03-13 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2025-03-13 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized controlled trial studying whether a 12-week Baduanjin exercise program (a traditional Chinese mind-body exercise) can reduce low back pain and improve quality of life in pregnant women.
Eligibility Criteria
Inclusion Criteria: * Single pregnancy (carrying one fetus). * Gestational age: 14-20 weeks at enrollment. * No contraindications to exercise during pregnancy (as determined by medical evaluation). Exclusion Criteria: * Adverse pregnancy symptoms: * Dizziness, blurred vision, vaginal bleeding, or other high-risk signs. * Pre-existing medical conditions: Orthopedic, cardiovascular, or psychiatric diseases; cognitive impairment. * Pregnancy complications: Preterm labor, placenta previa. * Inability to attend regular prenatal check-ups.
Contact & Investigator
Liangkun Ma
STUDY CHAIR
Chinese Academy of Medical Science & Peking Union Medical College Hospital
Frequently Asked Questions
Who can join the NCT07153653 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Pregnancy-related Low Back and Pelvic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07153653 currently recruiting?
Yes, NCT07153653 is actively recruiting participants. Contact the research team at maliangkun@pumch.cn for enrollment information.
Where is the NCT07153653 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07153653 clinical trial?
NCT07153653 is sponsored by Peking Union Medical College Hospital. The principal investigator is Liangkun Ma at Chinese Academy of Medical Science & Peking Union Medical College Hospital. The trial plans to enroll 84 participants.